NCT05747092

Pain Killer, Anxiety and Mucogingival Therapy

Is Pain Killer Cunsumption Dependent to Anxiety or Mucogingival Therapy?

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: University of Liege · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Accepted

Summary

Is the pain killer consumption after gingival treatment related to the level of patient anxiety or to the type of therapy?

Detailed description

Anxiety and depression (HAD) scale used could be reveal the level of the patient anxiety and/or depression before intervention. Additionnaly the use of these specific questionnaires (7 items for anxiety, 7 items for depression) could reveal if the pain killer consumption after gingical treatment is dependant to the level of HAD or to the therapy . This tool (HAD) could allows to recognize, before any (oral)surgery, profil with high risk and propose solution to decrease anxiety and/or depression before treatment.

Conditions

• Anxiety and Depression

Interventions

Type	Name	Description
PROCEDURE	gingival graft	investigators: Donor site: * tissue graft harvesting from the palate behind the palatal rugae . * placement of a palatine hemostatic plaque on the palate in order to reduce the risk of bleeding and to diminish the postoperative pain. Received site: * Control: the horizontal incision adjacent to the recession(s) and vertical incisions and split thickness flap. Placement of the graft on the recipient bed and suture. * Test :connective tissue graft using the " envelope/pouch " technique with two partial thickness incisions (deep and superficial). Placement of the graft inside the envelope

Timeline

• Start date: 2022-01-14
• Primary completion: 2023-02-14
• Completion: 2023-06-01
• First posted: 2023-02-28
• Last updated: 2023-02-28

Locations

1 site across 1 country: Belgium